Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02576275
Title A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Infinity Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Plainville Connecticut 06062 United States Details
Plantation Florida 33322 United States Details
Thomasville Georgia 31792 United States Details
East Setauket New York 11733-3456 United States Details
Cookeville Tennessee 38501 United States Details
Knoxville Tennessee 37909 United States Details
Spokane Washington 99208 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field